Therapy Areas: Oncology
AstraZeneca reports positive Phase III data for Imfinzi and Imjudo in liver cancer
...
Mary's Medicinals to participate in CMS trial programme with cannabinoid-based wellness products
2 April 2026 - Denver-based Mary's Medicinals, a subsidiary of MM Brands Inc, announced on Wednesday its intent to participate in the newly established Centers for Medicare & Medicaid Service...
Thermo Fisher Scientific unveils CHOvantage GS Kit to speed biologics development
1 April 2026 - Thermo Fisher Scientific Inc (NYSE: TMO) announced on Wednesday that it has unveiled its next-generation Gibco CHOvantage GS Cell Line Development (CLD) Kit, an integrated platform desi...
Frontier Medicines licenses FMC-220 oncology programme to LG Chem in global deal
1 April 2026 - Frontier Medicines Corporation, a clinical-stage precision medicines company, announced on Wednesday that it has entered into an exclusive licensing agreement with South Korean chemical...
Natera study shows Signatera MRD may help select breast cancer patients for non-surgical management
31 March 2026 - Cell-free DNA testing company Natera Inc (NASDAQ:NTRA) on Tuesday reported publication of a prospective study in Clinical Cancer Research demonstrating that its Signatera molecular res...
GSK's bepirovirsen accepted for review in China as potential Hepatitis B functional cure
30 March 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) announced on Monday that China's National Medical Products Administration has accepted for review a new drug application f...